Provention Bio Completes Enrollment of Phase 2a PRINCE Clinical Trial with PRV-6527 in Patients with Moderate to Severe Crohn's Disease

Stock Information for Provention Bio Inc.

Loading

Please wait while we load your information from QuoteMedia.